# Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease

> **NCT00849316** · — · WITHDRAWN · sponsor: **Novo Nordisk A/S**

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Chronic Kidney Disease

## Interventions

- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00849316
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-02
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to company decision to focus resources on the finalisation of three ongoing studies in the region
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849316, "Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00849316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*